Sickle Cell Anemia Screening and Prevention in Northern Israel

Summary of the Data From the Prevention Programme for Hemoglobinopathies in Northern Israel

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00735488

Enrollment

Registered

2008-08-15

Start date

2008-05-31

Completion date

2009-03-31

Last updated

2015-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sickle Cell Anemia, Thalassemia

Keywords

Thalassemia, Sickle cell anemia, Carrier detection, Prenatal Diagnosis, Genetic counseling

Brief summary

Since 1987, a screening for β Thalassemia in pregnant women is carried on in northern Israel, and from 1999 all the samples were tested also for Hgb S, Hgb C, Hgb D, Hgb O Arab and others. In this study, the investigators intend to summarize the results of this preventive program aiming to detect couples at risk for having offspring with Thalassemia or SCA, the compliance regard to genetic counseling and prenatal diagnosis and the incidence of new affected babies born.

Interventions

OTHERObservational

Summary of data

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

All pregnant women tested and their husband in those cases that the woman test revealed abnormal hemoglobin.

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Number of carriers detected	End of study

Secondary

Measure	Time frame
Couples referred for prenatal diagnosis	End of study

Countries

Israel

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026